August FDA Women's Health Update

"FDA Office of Women's Health" <fda@xxxxxxxxxxxxxxxxxxxxxxx> · Mon, 11 Aug 2014 14:05:23 -0500

Title:     August FDA Women's Health Update

            August 2014
www.fda.gov/womens

            Message from the Director
As you transition from your summer outreach to

planning for fall activities, I encourage you to look to FDA for resources. In

this update, you will find links to back-to-school resources, tips for

breastfeeding mothers, and announcements for several upcoming meetings and

conference exhibits.

           FDA Women's Health highlights

           Registration Open for FDA Meetings on Female Sexual Dysfunction

FDA will conduct a Patient-Focused

Drug Development Public Meeting and a Scientific Workshop on female sexual dysfunction

(FSD) on October 27 – 28, 2014 at FDA’s White Oak Campus in Silver Spring, MD.

On Day 1, FDA is interested in obtaining patient input on the most common form

of FSD, female sexual interest/arousal disorder (FSIAD). On Day 2, there will

be a scientific workshop to discuss how best to facilitate the development of

safe and effective drug therapies to treat FSIAD and how best to identify valid

patient-reported outcome measures to determine whether disease symptoms improve

with specific interventions. 

Register

for the Meeting:

http://patient-focused-female-sexual-dysfunction.eventbrite.com 
Wrinkle Fillers and other Facial Fillers

Wrinkle

fillers, also known as dermal fillers or facial soft tissue fillers, are approved

by FDA for use in helping to create a smoother and/or fuller appearance in the

face. These products are used for correcting defects in the face, such as

moderate to severe facial wrinkles and skin folds, lip and cheek augmentation,

and to restore or correct the signs of facial fat loss in people with HIV. Most

dermal fillers injected into the skin have a temporary effect, because over

time they are absorbed by the body. FDA has approved only one product made from

a material that remains in the body and is not absorbed.

FDA has

not approved dermal fillers for increasing breast or buttock size or for

injections anywhere other than in the face. FDA has not approved liquid

silicone or silicone gel for injection to fill wrinkles or augment tissues

anywhere in the body.

Get the Facts before Using

Fillers: 

Consumer

Update: Filling in Wrinkles Safely

Dermal

Fillers

List

of Approved Dermal Fillers

           Back to School Resources

FDA has

resources to help parents of young children, teens, and college students prepare

for the school year. Use these resources to help keep students safe. 

 College Women’s Health webpage 

The

Real Cost – Youth Tobacco Prevention 
Vaccines

for Children: A Guide for Parents 

Medication

Tips for Parents

Food

Safety and Nutrition Materials for Kids 
Pregnancy Twitter Chat: August 28
FDA’s

Office of Women’s Health (@FDAWomen)

is joining the National Institute of Child Health and Human Development (@NICHD_NIH) and @MarchofDimes for a #pregnancychat

on Twitter on August 28 from 2–3 p.m. EDT.  The chat will focus on ways in which women can

ensure a healthy pregnancy. It will also highlight Know Your Terms,

NIH’s new initiative for parents-to-be and health care professionals.

                              Extras

           FDA Resources for Breastfeeding Mothers

Breast pumps are medical devices regulated by the FDA. These

devices are often used by breastfeeding women to extract (“express”) their

breast milk. FDA has general tips to help women choose, use, and clean breast

pumps. 

Breast

Pumps Website

Consumer

Update: Breast Pumps: Don’t Be Misled

Other

Tips for Pregnant Women and New Mothers 

            FDA Meetings

PUBLIC HEARING: Confidentiality of Interim Results in

Cardiovascular (CV) Outcomes Safety Trials

August

11, 2014 - 8 a.m. to 5 p.m.

FDA

White Oak Campus, Silver Spring, MD

OWH Conference Exhibits

National Conference on Health

Communication, Marketing & Health – August 19-21, Atlanta, GA

National

Alliance on Mental Illness –September 4-5, Washington,

DC 

      Please share this update with your network, members, constituents, and community

FDA Office of Women's Health
10903 New Hampshire Avenue
WO32 - Room 2333
Silver Spring, MD 20993*0002
301-796-9440

Subscriber Services: 
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420